Skip to Content
About Us Become an Authorised Buyer Medical Partners Blog Contact Us
🌐Ship toSelect country
  1. All products
  2. Shop by Brand
  3. Revolax Fine Lidocaine - 1 x 1,1ml
  4. Shop by Brand
Pricelist: Default Pricelist
Pricelist: Default Pricelist
Revolax Fine Lidocaine - 1 x 1,1ml

Revolax Fine Lidocaine - 1 x 1,1ml

Revolax Fine is the lightest-viscosity product in Across Korea's Revolax range, a cross-linked hyaluronic acid filler (24mg/ml HA, 0.3% lidocaine) designed for superficial, fine lines — crow's feet, glabellar lines and neck wrinkles. It has the lowest complex viscosity in the range and is also suited to use with a Hyaluron Pen, with reported results lasting 9-12 months. For use by licensed, trained medical professionals only.

Cross-Linked Hyaluronic Acid Fine Lines Lidocaine
37.95 € 37.95 €
  • Brand
Contact Us
Terms and Conditions

Shipping: 
DHL EXPRESS SHIPPING (EU) — approx. 2-3 working days
STANDARD SHIPPING (EU) — approx. 7-10 working days
Select your delivery country in the header to check availability for your destination.
Category Fillers Brand Revolax
SKU A8801 Share
Treatment Areas Crow's FeetGlabella FoldsNeck
Tags Cross-Linked Hyaluronic AcidFine LinesLidocaine

Revolax Fine is a lighter-viscosity cross-linked hyaluronic acid dermal filler manufactured by Across Co. (South Korea), formulated for fine superficial lines and delicate facial areas. Formulated with lidocaine for a more comfortable injection experience.

CONCENTRATION

  • Cross-linked hyaluronic acid (fine formulation)
  • Lidocaine hydrochloride

THE PACK INCLUDES

  • 1 x 1.1ml Syringe

STORAGE CONDITIONS

  • Store between 2°C and 25°C

RESULTS & DURATION

Results typically last 6-9 months, depending on individual metabolism.

INDICATIONS

  • Fine superficial lines
  • Delicate facial areas

TREATMENT AREAS

  • Crow's feet
  • Perioral folds
  • Face, general

Revolax Fine is injected into the superficial to mid dermis using fine linear threading technique.

Results are visible immediately, with final results assessed after 1-2 weeks.

  • Pregnancy or breastfeeding
  • People under the age of 18
  • Active infection or inflammation at the treatment site
  • Known hypersensitivity to hyaluronic acid or lidocaine
  • Patients prone to hypertrophic scarring
  • Autoimmune diseases affecting the skin